Biocon: Launching a New Cancer Drug in India
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
Collection: HBSP (USA)
Ref: HBS-508026-E
Format: PDF
Number of pages: 15
Publication Date: Aug 28, 2007
Language: English
Review date: Nov 26, 2008
What material is included in this case:
Description
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
Read more
Year: Event Year Start:2006
Geographic Setting: Geographic Setting:India
Industry Setting: Industry Setting:Biotechnology
Leave your rating
"Biocon: Launching a New Cancer Drug in India"
Register for free with IESE Publishing and enjoy all the advantages
What type of account do you want to create?
Choose account type
Professors
Academic Institutions
Companies
Individuals